Nj State Employees Deferred Compensation Plan Biogen Inc. Transaction History
Nj State Employees Deferred Compensation Plan
- $789 Million
- Q2 2024
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Biogen Inc. stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 2,500 shares of BIIB stock, worth $504,500. This represents 0.07% of its overall portfolio holdings.
Number of Shares
2,500
Previous 2,500
-0.0%
Holding current value
$504,500
Previous $539,000
7.42%
% of portfolio
0.07%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding BIIB
# of Institutions
1,050Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.35 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$3.3 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.93 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.43 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$1.15 Billion0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $29.1B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...